“Clinical Considerations for the Management of Advanced PD-L1 ≥50% Non-small Cell Lung Cancer In 2025: Should All Patients Be Treated the Same?” (2025) Canadian Oncology Today, 2(1), pp. 13–17. doi:10.58931/cot.2025.2131.